Patient-reported benefits for future non-alcoholic steatohepatitis therapy: a global real-world study among 1,035 patients across 12 countries

被引：0
|
作者：
Higgins, Victoria [1 ]
Williams, Nathan [1 ]
Jackson, Jessica [1 ]
Williams, Rhys [1 ]
Piercy, James [1 ]
机构：
[1] Adelphi Real World, Metab Franchise, Bollington, England
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI122
引用
收藏
页码：S458 / S459
页数：2
相关论文
共 50 条
  • [41] Healthcare cost and resource utilization among patients with non-alcoholic steatohepatitis (NASH), stratified by glucagon-like peptide 1 receptor agonist (GLP-1) use in real world data
    Kim, Yestle
    Fishman, Jesse
    Tapper, Elliot
    Lewandowski, Dave
    Marlin, Taylor
    Bogdanov, Alina
    Bonafede, Machaon
    JOURNAL OF HEPATOLOGY, 2024, 80 : S611 - S612
  • [42] Clinical and Patient-Reported Outcomes of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Among Patients on Opioid Agonist Treatment: A Real-world Prospective Cohort Study
    Schulte, Bernd
    Schmidt, Christiane S.
    Manthey, Jakob
    Strada, Lisa
    Christensen, Stefan
    Cimander, Konrad
    Goerne, Herbert
    Khaykin, Pavel
    Scherbaum, Norbert
    Walcher, Stefan
    Mauss, Stefan
    Schaefer, Ingo
    Verthein, Uwe
    Rehm, Juergen
    Reimer, Jens
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (08):
  • [43] LUMINATE 102: A real-world study on biomarker testing rates among patients with non-small cell lung cancer (NSCLC) across lines of therapy
    Aggarwal, C.
    Xu, Q.
    Ng, S.
    Kamalakar, R.
    Crawford, S. A.
    Beruti, S.
    Myftiu, A.
    Beasley, M. B.
    ANNALS OF ONCOLOGY, 2023, 34
  • [44] Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of Cancers During Chemoradiation Therapy: Real-World Study
    Kang, Danbee
    Kim, Sooyeon
    Kim, Hyunsoo
    Lee, Mangyeong
    Kong, Sun-Young
    Chang, Yoon Jung
    Sim, Sung Hoon
    Kim, Yeon-Joo
    Cho, Juhee
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2023, 9 (01):
  • [45] IMPROVEMENTS IN PATIENT-REPORTED IMPACT OF PSORIATIC ARTHRITIS WITH IL-12/23 (USTEKINUMAB) OR TUMOUR NECROSIS FACTOR INHIBITORS: 1-YEAR DATA FROM THE LARGE, REAL-WORLD PsABIO STUDY
    Gossec, L.
    Siebert, S.
    Bergmans, P.
    De Vlam, K.
    Gremese, E.
    Joven-Ibanez, B.
    Korotaeva, T.
    Noel, W.
    Nurmohamed, M.
    Sfikakis, P.
    Theander, E.
    Smolen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 799 - 800
  • [46] Physician-assessed effectiveness and patient-reported outcomes in adult and adolescent patients with atopic dermatitis treated with dupilumab: real-world insights 1 year into the GLOBOSTAD multinational prospective observational study
    Ferrucci, Silvia M.
    Calzavara-Pinton, Piergiacomo
    Murrell, Dedee F.
    Fougerousse, Anne-Claire
    Karlova, Iva
    Lapeere, Hilde
    Holzer, Gregor
    Al-Ahmad, Mona
    Chu, Chia-Yu
    Foti, Caterina
    Perez-Garcia, Bibiana
    Wu, Jiangming
    Ardeleanu, Marius
    Bosman, Kwinten
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II34 - II34
  • [47] Physician-assessed effectiveness, patient-reported outcomes, and safety in adult and adolescent patients with atopic dermatitis treated with dupilumab: real-world insights 1 year into the GLOBOSTAD multinational prospective observational study
    Ferrucci, Silvia M.
    Calzavara-Pinton, Piergiacomo
    Murrell, Dedee F.
    Fougerousse, Anne-Claire
    Karlova, Iva
    Lapeere, Hilde
    Holzer, Gregor
    Al-Ahmad, Mona
    Chu, Chia-Yu
    Foti, Caterina
    Perez-Garcia, Bibiana
    Petrova, Anastasia
    Wu, Jiangming
    Ardeleanu, Marius
    Bosman, Kwinten
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : I56 - I57
  • [48] REAL-WORLD CLINICAL AND PATIENT-REPORTED OUTCOME DATA OF PATIENTS WITH NEWLY DIAGNOSED, ADVANCED OVARIAN CANCER - THE GERMAN PROSPECTIVE, NON-INTERVENTIONAL SCOUT-1 STUDY (NOGGO ov54, NCT04830709)
    Arndt, Tjadina
    Pietzner, Klaus
    Braicu, Elena Ioana
    Wimberger, Pauline
    Rose, Matthias
    Sehouli, Jalid
    ANTICANCER RESEARCH, 2023, 43 (07) : 3367 - 3368
  • [49] Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-up Results from an Observational Real-World Study Among Patients with Inflammatory Bowel Disease in the US and Canada (the ONWARD Study)
    Bincy Abraham
    Bertus Eksteen
    Khan Nedd
    Hrishikesh Kale
    Dipen Patel
    Jennifer Stephens
    Ahmed Shelbaya
    Richard Chambers
    Arif Soonasra
    Advances in Therapy, 2022, 39 : 2109 - 2127
  • [50] Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-up Results from an Observational Real-World Study Among Patients with Inflammatory Bowel Disease in the US and Canada (the ONWARD Study)
    Abraham, Bincy
    Eksteen, Bertus
    Nedd, Khan
    Kale, Hrishikesh
    Patel, Dipen
    Stephens, Jennifer
    Shelbaya, Ahmed
    Chambers, Richard
    Soonasra, Arif
    ADVANCES IN THERAPY, 2022, 39 (05) : 2109 - 2127
12345